Professor Jason J. Luke: - The cancer treatment landscape is exploding with possibilities

Legemidler og biotek
Video
Patients with malignant tumors treated with immunotherapy have received significant clinical benefits over the years. Immune checkpoint blocking agents such as anti-CTLA-4 and anti-PD-1 monoclonal antibodies, have produced impressive clinical results in different types of cancer. - Our emphasis is to completely cure the patients. However over the near term, really maximizing the use of drugs that we have to improve the survival of individual patients is what we are going to focus on.